UroGen Pharma
URGN
URGN
84 hedge funds and large institutions have $347M invested in UroGen Pharma in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $2.26M
34% less capital invested
Capital invested by funds: $527M → $347M (-$180M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
84
Holding in Top 10
2
Calls
$1.63M
Puts
$2.26M
Top Buyers
| 1 | +$17.8M | |
| 2 | +$10M | |
| 3 | +$5.07M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4.01M |
| 5 |
Goldman Sachs
New York
|
+$1.65M |
Top Sellers
| 1 | -$51.5M | |
| 2 | -$8.05M | |
| 3 | -$3.26M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.38M |
| 5 |
AI
Atom Investors
Austin,
Texas
|
-$2.26M |